Ultrasound drug targeting to tumors with thermosensitive liposomes

IEEE International Ultrasonics Symposium, IUS

Volumn , Issue , 2011, Pages 1-4

  Ernsting, Mark J ^a   Worthington, Arthur ^b   May, Jonathan P ^a   Tagami, Tatsuaki ^a   Kolios, Michael C ^b   Li, Shyh Dar ^a  

^a ONTARIO INSTITUTE FOR CANCER RESEARCH   (Canada)

^b RYERSON UNIVERSITY   (Canada)

Author keywords

cancer; hyperthermia; thermosensitive liposome; ultrasound

Indexed keywords

BALB/C MICE; BODY TEMPERATURE; BREAST CANCER TUMORS; BREAST TUMOR; CANCER; CANCER THERAPY; DOXORUBICIN; DRUG-TARGETING; DYNAMIC CONTROLS; HISTOLOGICAL EXAMINATION; HYPERTHERMIA; NORMAL TISSUE; PHYSIOLOGICAL DAMAGES; PLANAR TRANSDUCERS; POST TREATMENT; RELEASE PROFILES; TEMPERATURE PROFILES; THERMOSENSITIVE LIPOSOMES; TUMOR INHIBITION; ULTRASOUND HEATING;

CHEMOTHERAPY; DISEASES; HISTOLOGY; MAMMALS; PHYSIOLOGY; TUMORS;

ULTRASONICS;

EID: 84869054605     PISSN: 19485719     EISSN: 19485727     Source Type: Conference Proceeding    
DOI: 10.1109/ULTSYM.2011.0001     Document Type: Conference Paper

References (24)

1. Dromi S, Frenkel V, Luk A, Traughber B, Angstadt M, Bur M, et al. Pulsed-high intensity focused ultrasound and low temperature-sensitive liposomes for enhanced targeted drug delivery and antitumor effect. Clin Cancer Res. 2007;13:2722-7.
2. Kong G, Anyarambhatla G, Petros WP, Braun RD, Colvin OM, Needham D, et al. Efficacy of liposomes and hyperthermia in a human tumor xenograft model: importance of triggered drug release. Cancer Res. 2000;60:6950-7.
3. Poon RT, Borys N. Lyso-thermosensitive liposomal doxorubicin: a novel approach to enhance efficacy of thermal ablation of liver cancer. Expert Opin Pharmacother. 2009;10:333-43.
4. Needham D, Anyarambhatla G, Kong G, Dewhirst MW. A new temperature-sensitive liposome for use with mild hyperthermia: characterization and testing in a human tumor xenograft model. Cancer Res. 2000;60:1197-201.
5. Banno B, Ickenstein LM, Chiu GN, Bally MB, Thewalt J, Brief E, et al. The functional roles of poly(ethylene glycol)-lipid and lysolipid in the drug retention and release from lysolipid-containing thermosensitive liposomes in vitro and in vivo. J Pharm Sci.99:2295-308.
6. Mills JK, Needham D. Lysolipid incorporation in dipalmitoylphosphatidylcholine bilayer membranes enhances the ion permeability and drug release rates at the membrane phase transition. Biochim Biophys Acta. 2005;1716:77-96.
7. Ponce AM, Viglianti BL, Yu D, Yarmolenko PS, Michelich CR, Woo J, et al. Magnetic resonance imaging of temperature-sensitive liposome release: drug dose painting and antitumor effects. J Natl Cancer Inst. 2007;99:53-63.
8. Howard JH, Tzeng CW, Smith JK, Eckhoff DE, Bynon JS, Wang T, et al. Radiofrequency ablation for unresectable tumors of the liver. Am Surg. 2008;74:594-600; discussion -1.
9. Kang MK, Kim MS, Kim JH. Clinical outcomes of mild hyperthermia for locally advanced rectal cancer treated with preoperative radiochemotherapy. Int J Hyperthermia. 2011;27:482-90.
10. Kolios MC, Sherar MD, Hunt JW. Blood flow cooling and ultrasonic lesion formation. Med Phys. 1996;23:1287-98.
11. Kolios MC, Worthington AE, Holdsworth DW, Sherar MD, Hunt JW. An investigation of the flow dependence of temperature gradients near large vessels during steady state and transient tissue heating. Phys Med Biol. 1999;44:1479-97.
12. de Smet M, Heijman E, Langereis S, Hijnen N, Grull H. Magnetic resonance imaging of high intensity focused ultrasound mediated drug delivery from temperature sensitive liposomes; An in vivo proof-of-concept study. J Control Release. 2010.
13. Diederich CJ, Hynynen K. Ultrasound technology for hyperthermia. Ultrasound Med Biol. 1999;25:871-87.
14. Hauck ML, LaRue SM, Petros WP, Poulson JM, Yu D, Spasojevic I, et al. Phase I trial of doxorubicin-containing low temperature sensitive liposomes in spontaneous canine tumors. Clin Cancer Res. 2006;12:4004-10.
15. Ahmed M, Goldberg SN. Combination radiofrequency thermal ablation and adjuvant IV liposomal doxorubicin increases tissue coagulation and intratumoural drug accumulation. Int J Hyperthermia. 2004;20:781-802.
16. Staruch R, Chopra R, Hynynen K. Localised drug release using MRI-controlled focused ultrasound hyperthermia. Int J Hyperthermia. 2010.
17. Sherar MD, Moriarty JA, Kolios MC, Chen JC, Peters RD, Ang LC, et al. Comparison of thermal damage calculated using magnetic resonance thermometry, with magnetic resonance imaging post-treatment and histology, after interstitial microwave thermal therapy of rabbit brain. Phys Med Biol. 2000;45:3563-76.
18. Tagami T, Ernsting MJ, Li SD. Efficient tumor regression by a single and low dose treatment with a novel and enhanced formulation of thermosensitive liposomal doxorubicin. J Control Release. 2011;152:303-9.
19. Tagami T, Ernsting MJ, Li SD. Optimization of a novel and improved thermosensitive liposome formulated with DPPC and a Brij surfactant using a robust in vitro system. J Control Release. 2011;154:290-7.
20. Tagami T, Foltz WD, Ernsting MJ, Lee CM, Tannock IF, May JP, et al. MRI monitoring of intratumoral drug delivery and prediction of the therapeutic effect with a multifunctional thermosensitive liposome. Biomaterials. 2011;32:6570-8.
21. Danhier F, Feron O, Preat V. To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery. J Control Release. 2010;148:135-46.
22. Heneweer C, Holland JP, Divilov V, Carlin S, Lewis JS. Magnitude of enhanced permeability and retention effect in tumors with different phenotypes: 89Zr-albumin as a model system. J Nucl Med. 2011;52:625-33.
23. Fleming JM, Miller TC, Meyer MJ, Ginsburg E, Vonderhaar BK. Local regulation of human breast xenograft models. J Cell Physiol. 2010;224:795-806.
24. Hynynen K, Shimm D, Anhalt D, Stea B, Sykes H, Cassady JR, et al. Temperature distributions during clinical scanned, focused ultrasound hyperthermia treatments. Int J Hyperthermia. 1990;6:891-908.